Table 2. Characteristics of anti-HBe seroconverters compared to those with no seroconversion.
| No antiHBe seroconversion | antiHBe seroconversion | P value | |
| (n = 15) | (n = 12) | ||
| Male Gender | 60% (n = 9) | 67% (n = 8) | 0.722 |
| Median age (years) | 32.5 | 30 | 0.283 |
| Median nadir CD4 (cells/mm3) | 46 | 32 | 0.341 |
| Median pre-HAART HBV DNA (log10 IU/ml) | 8.00 | 8.34 | 0.380 |
| Median pre HAART ALT (IU/ml) | 30 | 48 | 0.034 |
| Median HBV DNA decline to week 24 (log10 IU/ml) | 6.14 | 7.42 | 0.045 |
| Median gain in CD4 to week 24 (cells/mm3) | 86 | 85 | 0.733 |
| HBV Genotype C | 10 (83%) | 13 (87%) | 0.809 |
| Median BL log HIV RNA | 4.68 | 5.06 | 0.435 |